Congenital canine myasthenia gravis: II. Acetylcholine receptor metabolism

Kenichiro Oda, Vanda A. Lennon, Edward H. Lambert, Anthony C. Palmer

Research output: Contribution to journalArticlepeer-review

13 Scopus citations


Acetylcholine receptor (AChR) metabolism was studied in muscle from juvenile and adult dogs with congenital myasthenia gravis (CMG) and their unaffected littermates. Although the amount of AChR in the junctional region of innervated CMG muscle fibers was 25% of normal, or less, denervation of CMG fibers resulted in the appearance of AChR in extrajunctional membranes at as high a concentration as in denervated normal fibers. The rate of degradation of junctional AChR in CMG fibers explanted to organ culture did not differ significantly from normal. In monolayer cultures derived from enzyme‐dissociated CMG muscle, myotubes of normal morphology developed, and the synthesis and degradation of AChR did not differ from normal. Addition of sera from dogs with the acquired autoimmune form of MG accelerated the degradation of AChR on cultured myotubes, but CMG dog sera were without effect. These data suggest that the low junctional membrane density of AChR in CMG does not reflect a primary inability of muscle to synthesize AChR, nor an accelerated degradation of AChR in the postsynaptic membrane, but rather a low insertion rate of AChR in the postsynaptic membrane.

Original languageEnglish (US)
Pages (from-to)717-724
Number of pages8
JournalMuscle & Nerve
Issue number9
StatePublished - Dec 1984

ASJC Scopus subject areas

  • Physiology
  • Clinical Neurology
  • Cellular and Molecular Neuroscience
  • Physiology (medical)


Dive into the research topics of 'Congenital canine myasthenia gravis: II. Acetylcholine receptor metabolism'. Together they form a unique fingerprint.

Cite this